The Evaluation of Pharmacokinetic/Pharmacodynamic Characteristics and Safety of QDX in Healthy Korean Male Subjects
PHASE1CompletedINTERVENTIONAL
Enrollment
42
Participants
Timeline
Start Date
July 1, 2020
Primary Completion Date
October 6, 2020
Study Completion Date
October 6, 2020
Conditions
Migraine
Interventions
DRUG
Topiramate
Topiramate
Trial Locations (1)
Unknown
Seoul National University Hospital, Dept. of Clinical Pharmacology, Seoul
All Listed Sponsors
lead
SK Chemicals Co., Ltd.
INDUSTRY
NCT04401137 - The Evaluation of Pharmacokinetic/Pharmacodynamic Characteristics and Safety of QDX in Healthy Korean Male Subjects | Biotech Hunter | Biotech Hunter